Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

In a report released today, Maury Raycroft from Jefferies maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report), ...

Roche's CEO said on Wednesday that the Swiss drugmaker's oral drug candidate for breast cancer giredestrant could enter a ...

Protecting the rights of Americans is my top priority. I believe in the power of the free-market and the importance of limited government overreach. However, today our health care system is under ...

The Pharma & Biotech market had a relatively positive month with 41.5% of the coverage universe posting positive share price ...

In the assessment of 12-month price targets, analysts unveil insights for Inovio Pharmaceuticals, presenting an average ...

Bristol-Myers Squibb Co (NYSE:BMY) is up 3.2% at $51.71, after the U.S. Food & Drug Administration (FDA) approved the pharma ...

AM(IST)on Wednesday in an upbeat market. Divi's Laboratories Ltd.(up 5.21 per cent), Sanofi India Ltd.(up 2.55 per cent), ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $10.0, a ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.30% to 1,913.60 Indian rupees Thursday, on what proved to be ...

Last year, the Food and Drug Administration (FDA) granted approval for CRISPR's gene therapy for sickle cell disease for ...